PUNE, India, October 26, 2016 /PRNewswire/ --
MarketReportsOnline.com adds Global Malignant Melanoma Market Report With Focus on Nevisense System: 2015-2020 research of 84 pages on the malignant melanoma industry to the pharmaceuticals intelligence collection of its research store.
The report titled "Global Malignant Melanoma Market With Focus on Nevisense System" provides an in-depth analysis of the global malignant melanoma market with detailed analysis of the volume of patients and deaths caused due to melanoma. The report also provides the market size of the global melanoma diagnosis and therapeutics market. Complete report on malignant melanoma market spread across 84 pages providing 3 company profiles and 2 tables and 56 figures is now available at http://www.marketreportsonline.com/497702.html.
The global malignant melanoma market is expected to have increased at the significant CAGR during 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The most affected regions around the world include Americas and Europe followed by Asia, Oceania and Africa. The most common environmental factors resulting in the high prevalence of melanoma include, sun exposure, artificial UV rays and social-economic status of individuals.
The growth drivers for the market are: rise in melanoma cases. Effective immunotherapies and targeted therapy drugs. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: lack of awareness among people, high treatment cost and challenges in the developing countries such as insufficient political priorities and funding issues.
Purchase a copy of this "Malignant Melanoma Market" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=497702.
The report provides detailed regional analysis of Americas, Europe, Asia, Oceania and Africa for the malignant melanoma market. Regional analysis includes the melanoma diagnosis and therapeutics market, total volume of melanoma patients and deaths caused by melanoma along with the gender segmentation. The report also includes the country analysis of the U.S. and Australia for malignant melanoma market. It provides the analysis of melanoma patient volume along with the deaths caused.
The malignant melanoma market report also provides detailed information and analysis on the first objective diagnostic support tool, named, Nevisense system manufactured by SciBase company. This section provides the detailed information about the features and clinical benefits of the device along with the technology of the device and its clinical procedures. This also includes the global and regional analysis of the number of devices sold since its invention, i.e. 2014, its installed base and the competitors.
Company coverage of Malignant Melanoma Market: Bristol-Myers Squibb Company, Merck & Co., Inc. & Navidea Biopharmaceuticals, Inc. Regional Coverage of Malignant Melanoma Market: Europe, Americas, Asia, Oceania & Africa
Furthermore, the malignant melanoma market report assesses key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global melanoma market has also been forecasted for the period 2015-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global melanoma market is stiff and dominated by the big players like Bristol. Further, key players of the melanoma market, Merck and Navidea are also profiled with their financial information and respective business strategies.
Inquire for a discount on this "Malignant Melanoma Market With Focus on Nevisense System" research report at http://www.marketreportsonline.com/contacts/discount.php?name=497702.
Few Points from List of Figures:
Figure 3: Global Melanoma Diagnosis and Therapeutics Market by Value; 2015-2020E (US$ Billion)
Figure 4: Flobal Melanoma Diagnosis and Therapeutics Market by Region; 2015 (%)
Figure 5: Global Melanoma Market by New Cases; 2012-2020E (Thousand)
Figure 6: Global Melanoma Market New Cases by Gender; 2012-2020E (Thousand)
Figure 8: Global Melanoma Market by Deaths Caused; 2012-2020E (Thousand)
Figure 9: Global Melanoma Market by Deaths Caused (Gender Segmentation); 2012-2020E (Thousand)
Figure 11: Europe Melanoma Diagnosis and Therapeutics Market by Value; 2015-2020E (US$ Million)
Figure 12: Europe Melanoma Market by New Cases; 2012-2020E (Thousand)
Figure 13: Europe Melanoma Market New Cases by Gender; 2012-2020E (Thousand)
Figure 14: Europe Melanoma Market by Deaths Caused; 2012-2020E (Thousand)
Figure 15: Europe Melanoma Market by Deaths Caused (Gender Segmentation); 2012-2020E (Thousand)
Figure 16: Americas Melanoma Market by New Cases; 2012-2020E (Thousand)
Figure 17: Americas Melanoma Market New Cases by Gender; 2012-2020E (Thousand)
Figure 18: Americas Melanoma Market by Deaths Caused; 2012-2020E (Thousand)
Explore more pharmaceuticals market research as well as other newly published reports by Daedal Research at http://www.marketreportsonline.com/publisher/daedal-research-market-research.html.
Market Reports Online comprises of an online library of 250,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd floor, Metropole, Next to Inox theatre,
Bund garden road, Pune-411001
Tel: + 1 888 391 5441
SOURCE Market Reports Online